Company Filing History:
Years Active: 2025
Title: Innovations by James Brenton in Cancer Research
Introduction
James Brenton is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly through his innovative methods for detecting variant nucleic acids and predicting treatment responses in cancer patients. With a total of 2 patents, his work is paving the way for advancements in cancer diagnostics and treatment.
Latest Patents
Brenton's latest patents include a method for enhanced detection of target DNA by fragment size analysis. This invention provides a computer-implemented method for detecting variant nucleic acid from a cell-free nucleic acid-containing sample. The method involves processing data representing fragment sizes of nucleic acid fragments and classifying the sample data to determine the presence of variant nucleic acid.
Another significant patent focuses on methods for predicting treatment response in cancers. This invention utilizes a tumor copy number profile to assess whether certain characteristics indicate the presence of focal amplifications in the tumor genome. The method predicts whether a patient is likely to be resistant to specific treatments based on the analysis of copy number features.
Career Highlights
James Brenton is associated with Cancer Research Technology Limited, where he continues to develop innovative solutions for cancer diagnostics and treatment. His work is instrumental in advancing the understanding of cancer biology and improving patient outcomes.
Collaborations
Brenton collaborates with talented individuals such as Anna Piskorz and Geoff Macintyre, contributing to a dynamic research environment focused on cancer innovation.
Conclusion
James Brenton's contributions to cancer research through his patents and collaborative efforts highlight the importance of innovation in improving cancer diagnostics and treatment strategies. His work continues to inspire advancements in the field.